reference/8001707

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8001707

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	482
issn	0009-9236 1532-6535
issueIdentifier	3
pageRange	475-482
publicationName	Clinical pharmacology and therapeutics
startingPage	475
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a4a4d52950e33267ecdc80a8f3c095ea http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5a0eb2fadabf1dffb4d70280b760adba
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_334b9082c5bacd8bd7278a886632beee http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_21be9680f0cd1de8a5844c5dfa53b61d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9f9170e98589b75e004c3900eeca8734 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ecdd1fc4453d75b7c5efc8e2d847fd5e http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d257eece78698ce94257a943d62f9a27 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9c9aa95571c11019a6d5b2b8208418ef http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_931c8dde207df29b9de137945003962f
bibliographicCitation	Michaud V, Ogburn E, Thong N, Aregbe AO, Quigg TC, Flockhart DA, Desta Z. Induction of CYP2C19 and CYP3A Activity Following Repeated Administration of Efavirenz in Healthy Volunteers. Clinical Pharmacology & Therapeutics. 2012 Feb 08;91(3):475–82. doi: 10.1038/clpt.2011.249.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_50e1e7a13e2fce1aec60892a1f73718b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_714c05171d73f81ac3c15de5b47356b9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e27dba0bca0408e7161026777231dcf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_99e428c1dac57b34f557c141651d1b8c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bbd62913c596ee063403ed6c099b5f05 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fce7378c94b82b7a4793986622cd4859 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_77b9a297e4ec9de2dee86c2f8e734af2
date	2012-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1038/clpt.2011.249 https://pubmed.ncbi.nlm.nih.gov/22318618 https://pubmed.ncbi.nlm.nih.gov/PMC3667659
isPartOf	https://portal.issn.org/resource/ISSN/0009-9236 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3058 https://portal.issn.org/resource/ISSN/1532-6535
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Induction of CYP2C19 and CYP3A Activity Following Repeated Administration of Efavirenz in Healthy Volunteers
discusses	http://id.nlm.nih.gov/mesh/M0082919 http://id.nlm.nih.gov/mesh/M0461882 http://id.nlm.nih.gov/mesh/M0000724 http://id.nlm.nih.gov/mesh/M0001774 http://id.nlm.nih.gov/mesh/M0015293 http://id.nlm.nih.gov/mesh/M0120444 http://id.nlm.nih.gov/mesh/M0438535 http://id.nlm.nih.gov/mesh/M0005491 http://id.nlm.nih.gov/mesh/M0028255 http://id.nlm.nih.gov/mesh/M0007520 http://id.nlm.nih.gov/mesh/M0258297 http://id.nlm.nih.gov/mesh/M0132976 http://id.nlm.nih.gov/mesh/M0590604
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4594 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119560 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID145900 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b360533648df9c14281910a5ec4e45f0 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64139

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129722732 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129288905 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1557 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID46506827 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129288902

Total number of triples: 61.